Back pain is a reason to think about osteoporosis
https://doi.org/10.14412/2074-2711-2011-139
Abstract
The paper gives information on osteoporosis (OP) as a cause of back pain. In OP the latter is stated to be induced by not only osteoporotic fractures, but also other pathological changes associated with bone mineral density loss. Data on the management of back pain due to OP are presented and the efficacies of alendronate and vitamin D3 are noted
About the Authors
A. L. Vertkin
Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
A. V. Naumov
Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
S. R. Shakirova
Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
D. M. Zaichenko
Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
N. N. Vladimirova
Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
E. V. Adonina
Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
References
1. <div><p>Brevik H., Collet B., Ventetridda V. Survey of chronic pain in Europe: prevalence, impact on daily life and treatment. Eur J Pain 2006;10:287-333.</p><p>Frymoyer J.W., Durett C.L., Frymoer J.W. et al. The economics of spinal disorders. In: Hadler NM, et al. (eds). The Adult Spine: Principles and Practices. Philadelphia, Pa: Lippincott-Raven, 1997.</p><p>Наумов А.В., Семенов П.А. Боль в России: факты и умозаключения. Consilium Medicum 2010;12(2):38-41.</p><p>Von Korff M., Crane P. , Lane M. et al. Chronic spinal pain and physical-mental comorbidity in the United States: Results from the National Comorbidity Survey replication. Pain 2005;113:331-9.</p><p>Верткин А.Л., Наумов А.В., Шамуилова М.М. и др. Дегенеративно-дистрофические заболевания костно-суставной системы в современной клинике. Решены ли проблемы? Клин геронтол 2008;14(2):53-9.</p><p>O'Neill T.W., Felsenberg D., Varlow J. and The European Vertebral Osteoporosis Study Group. The prevalence of vertebral deformities in European men and women: The European Vertebral Osteoporosis Study. J Bone Miner Res 1996;11:1010-7.</p><p>Лесняк О.М., Евстигнеева Л.П. Лечение и реабилитация больных с остеопорозными переломами позвонков. Рос семейный врач 2005;9:43-50.</p><p>Kanis J.A., Burlet N., Cooper C. et al. On behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399-428.</p><p>Шварц Г.Я. Витамин Д и Д-гормон. М.:Анахарсис, 2005;152 с.</p><p>Дамбахер М.А., Шахт Е. Остеопороз и активные метаболиты витамина Д: мысли, которые приходят в голову. Basel: Eular Publishers, 1996;139 p.</p><p>Taguchi Y., Yamamoto M., Yamate T. Proc Ass Am Physician 1998;110:559-74.</p><p>Manolagas S.C., Jilka R.L. Bone marrow, cytokines and bone remodeling. New Engl J Med 1995;332:305-11.</p><p>Berg J., Fellier H., Christoph T. et al. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflam Res 1999;48(7):369-79.</p><p>Jergensen N.R. Citokines and osteoporosis. Ugeskr Laeger 1997;160:24-8.</p><p>Pindel B., Pluskiewicz W. The role of locally synthesized growth factors and cytokines in patogenesis of Osteoporosis. Chir Narzadow Ruchu Ortop Pol 1996;61:487-91.</p><p>Martins D., Wolf M., Pan D. et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007;167(11):1159-65.</p><p>Thacher T.D., Clarke B.L. Vitamin D Insufficiency. Mayo Clin Proc 2011 Jan;86(1):50-60.</p><p>Arvold D.S., Odean M.J., Dornfeld M.P. et al. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 2009;15(3):203-12.</p><p>Dawson-Hughes B., Mithal A., Bonjour J.-P. et al. IOF position statement: vitamin D recommendations for older adults. Osteoporosis Int 2010;(7):1151-4.</p><p>Pols H.A., Felsenberg D., Hanley D.A. et al. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Foxamax International Trial Study Group. Osteoporosis Int 1999;9:461-8.</p><p>Black D.M., Cummings S.R., Karpf D.B. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535-41.</p><p>Kanis J.A., Burlet N., Coope C. et al. on behalf of the European Society for Clinicaland Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis Int 2008;19:399-428.</p><p>Rizzoli R., Greenspan S.L., Bone G. 3rd et al. Two-year results of once-weekly administration of alendronate 70 mg for the treatment of post-menopausal osteoporosis. J Bone Mineral Res 2002;17(11):1988-96.</p></div><br />
Review
For citations:
Vertkin AL, Naumov AV, Shakirova SR, Zaichenko DM, Vladimirova NN, Adonina EV. Back pain is a reason to think about osteoporosis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2011;3(1):75-80. (In Russ.) https://doi.org/10.14412/2074-2711-2011-139
Views:
904
Email this article 